01—Abstract
Summary
Summary of the 8-K filed December 18, 2025. Cited figures are marked; the original filing is the authoritative source.
On December 18, 2025, Zoetis completed a $2.0 billiona private offering of 0.25% Convertible Senior Notes due June 15, 2029, including the $250 million over-allotment option that was exercised in full.
Net proceeds are approximately $1,969.6 millionb. The company plans to use roughly $186.6 million for capped call transactions, $248.0 million for a privately negotiated repurchase of about 2.1 million shares, and the remaining approximately $1,535.0 million for additional open-market or privately negotiated buybacks under its existing $6 billion repurchase program, expected to be completed by Q1 2026. The effect is a large, debt-funded share repurchase that is designed to be largely offset in dilution terms by the capped calls.
The notes carry a low 0.25% coupon and an initial conversion price of about $148.20c, a 22.5% premium to the December 15, 2025 closing price. Zoetis has the option to settle conversions in cash, shares, or a combination, and it must pay cash at least up to principal. The capped calls, with a $211.72 cap (75% premium), cover roughly 13.5 million shares and are intended to reduce dilution up to that price.
The maximum potential share issuance is about 13.5 million shares, or 16.5 million including make-whole adjustments. The notes are senior unsecured obligations, and the filing discloses a waiver under the revolving credit facility that permits early conversions. For investors, the transaction shifts the capital structure toward low-cost convertible debt and reduces the share count in the near term, which can support per-share metrics.
Key risks include the added leverage of roughly $2 billiond, potential hedge-related trading activity around conversion or repurchase windows, and the execution of the buyback program over the coming months. The filing is a financing and capital-allocation event rather than a change in operating performance.
02—Key points
Key Highlights
- $2.0 billion 0.25% Convertible Senior Notes due 2029 issued, including $250 million exercised option; net proceeds about $1,969.6 million
- Initial conversion price of about $148.20 per share, a 22.5% premium to the December 15, 2025 closing price
- Approximately $1.6 billion of net proceeds (about $248 million privately negotiated plus about $1.5 billion additional buybacks) directed to share repurchases under the existing $6 billion program, expected complete by Q1 2026
- Capped calls with a $211.72 cap price (75% premium) covering about 13.5 million shares, intended to reduce dilution up to the cap
- Maximum potential share issuance of about 13.5 million shares (16.5 million with make-whole adjustments), with Zoetis able to settle principal in cash
- Notes are senior unsecured; Events of Default include cross-default on indebtedness over $250 million, with a 30-day cure period
- Revolving credit facility waiver obtained to permit early conversions of the notes
03—Questions
Frequently Asked Questions
Why is Zoetis issuing convertible notes and how will the proceeds be used?
Zoetis is using the net proceeds of about $1,969.6 million to fund capped call transactions (about $186.6 million), purchase about 2.1 million shares for about $248.0 million in a privately negotiated deal, and repurchase the remaining roughly $1,535.0 million of stock on the open market or in private transactions by Q1 2026 under its existing $6 billion program.
How could the notes dilute existing shareholders?
Zoetis must pay cash up to the principal amount on conversion, and it can choose to settle any excess in cash, shares, or a combination. The maximum potential share issuance is about 13.5 million shares, or 16.5 million including make-whole adjustments. The capped calls, which cover about 13.5 million shares up to a $211.72 cap price, are designed to offset dilution and cash payments above principal up to that price.
When can holders convert the notes, and when can Zoetis redeem them?
Holders may convert before March 15, 2029 only under specified conditions, such as the stock trading at or above 130% of the conversion price for a specified period, certain trading price triggers, or corporate events. From March 15, 2029 until the second trading day before maturity, conversion is unrestricted. Zoetis may redeem the notes for cash at par plus accrued interest on or after December 20, 2027, if the stock trades at or above 130% of the conversion price for a specified period.
What are the main risks and obligations tied to the notes?
The notes are senior unsecured obligations with a 0.25% coupon payable semiannually. Events of Default include failure to pay interest or principal, failure to convert or give required notices, cross-default on debt over $250 million, and bankruptcy events. Holders can require repurchase at par on a fundamental change. The company is adding about $2.0 billion of debt, which increases leverage, and hedging activity by counterparties could affect the stock price around conversion or repurchase periods.
04—Continue